You are here

Article info

Article menu
Basic tumor immunology
Original research
Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis’

Authors

  • Jinyan Liu Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Huanan Chen Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaDepartment of Medical Record Management and Statistics, Shandong Provincial, Qianfoshan Hospital, The First Affiliated Hospital of Shandong First Medical University, Jinan, China PubMed articlesGoogle scholar articles
  • Caijuan Guo Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Jieyao Li Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Miaomiao Li Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Ming Zhao Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Ziyi Fu Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Zhen Zhang Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Feng Li Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Xuan Zhao Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Li Yang Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Liping Wang Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Quanjun Lv Department of Nutrition and Food Hygiene, College of Public Health, and the First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China PubMed articlesGoogle scholar articles
  • Yi Zhang Biotherapy Center and Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, ChinaState Key Laboratory of Esophageal Cancer Prevention & and Treatment, Zhengzhou, Henan, ChinaSchool of Life Sciences, Zhengzhou University, Zhengzhou, Henan, People's Republic of China PubMed articlesGoogle scholar articles

Citation

Liu J, Chen H, Guo C, et al
Sulforaphane activates CD8+ T cells antitumor response through IL-12RB2/MMP3/FasL-induced MDSCs apoptosis’
Journal for ImmunoTherapy of Cancer 2024;12:e007983. doi: 10.1136/jitc-2023-007983
Online issue publication 
January 31, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.